Free Trial
→ Banks aren’t ready for this altcoin—are you? (From Crypto 101 Media) (Ad)

10 Best Small Cap Stocks to Buy Now - 10 of 10

Slide 10
Back to 9
Next Slideshow
 
Back to 9
Next Slideshow
 

Maze Therapeutics (NASDAQ:MAZE)

Consensus Rating
Buy
Rating Score
3.4
Ratings Breakdown
5 Buy Ratings, 0 Hold Ratings, 0 Sell Ratings.
Consensus Price Target
$25.67 (98.5% Upside)

About Maze Therapeutics

Maze Therapeutics logoWe are a clinical-stage biopharmaceutical company harnessing the power of human genetics to develop novel, small molecule precision medicines for patients living with renal, cardiovascular and related metabolic diseases, including obesity. We are advancing a pipeline using our Compass platform, which allows us to identify and characterize genetic variants in disease and then link those variants to the biological pathways that drive disease in specific patient groups through a process we refer to as variant functionalization. More about Maze Therapeutics
 

Recent Analyst Ratings

DateBrokerageActionRatingPrice TargetDetails
4/2/2025GuggenheimReiterated RatingBuy ➝ Buy$19.00 ➝ $19.00
2/25/2025TD CowenUpgradeStrong-Buy
2/25/2025Leerink PartnrsUpgradeStrong-Buy
2/25/2025GuggenheimInitiated CoverageBuy$19.00
2/25/2025JPMorgan Chase & Co.Initiated CoverageOverweight$30.00
2/25/2025Leerink PartnersInitiated CoverageOutperform$28.00

More Investing Slideshows:

Slide 10
Back to 9
Next Slideshow
 

More From MarketBeat
AI Meltdown Imminent: Dump These Stocks Now!
If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...
Paradigm Press | Sponsored
7 Stocks on Track for Dividend Increases in First Half of 2025
In relative terms, dividend stocks have underperformed the market. For example, the SPDR Portfolio S&P 5...
MarketBeat
Your Bank Account Is No Longer Safe
What If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...
Priority Gold | Sponsored
7 Stocks Changing the World—and Making Investors Wealthy
Technology is evolving faster than ever. Disruptive technology that was seen as groundbreaking just a decade...
MarketBeat
Utah’s New Oil Find
The Real Reason 218,000 Acres Just Vanished The government just quietly leased 218,000 acres in the middle ...
Stansberry Research | Sponsored
10 Cheap Stocks Under $10 to Buy Now
The stock market has largely recovered from its 2022 and 2023 slowdown and continues to hit new all time highs...
MarketBeat